Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis

OBJECTIVE: This study aimed to evaluate retrospectively the outcomes of Abobotulinumtoxin-A (Dysport®) intravesical injection in refractory interstitial cystitis/bladder pain syndrome patients to first- and second-line treatment. MATERIALS AND METHODS: From March 2016 to 2021, 44 adult patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahnama’i, Mohammad-Sajjad, Salehi-Pourmehr, Hanieh, Saeedi, Sana, Tayebi, Sona, Hajebrahimi, Sakineh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Association of Urology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346116/
https://www.ncbi.nlm.nih.gov/pubmed/37877871
http://dx.doi.org/10.5152/tud.2023.22243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346116/
https://www.ncbi.nlm.nih.gov/pubmed/37877871
http://dx.doi.org/10.5152/tud.2023.22243

Ejemplares similares